Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. SEM
SEM logo

SEM Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Select Medical Holdings Corp (SEM) Today? Analysis, Price Targets, and 2026 Outlook.

No data

No data

No data

No data

Growth

Profitability

Efficiency

Wall Street analysts forecast SEM stock price to rise
4 Analyst Rating
Wall Street analysts forecast SEM stock price to rise
4 Buy
0 Hold
0 Sell
Strong Buy
Current: 16.660
sliders
Low
17
Averages
18.75
High
21
Current: 16.660
sliders
Low
17
Averages
18.75
High
21
Mizuho
Ann Hynes
Outperform -> Neutral
downgrade
$17
AI Analysis
2026-05-12
Reason
Mizuho
Ann Hynes
Price Target
$17
AI Analysis
2026-05-12
downgrade
Outperform -> Neutral
Reason
Mizuho analyst Ann Hynes downgraded Select Medical to Neutral from Outperform with a price target of $16.50, down from $17. The company is being taken private with the deal expected to close in mid-2026, pending shareholder approval, the analyst tells investors in a research note. Mizuho views the $16.50 in cash per share price as fair.
RBC Capital
Outperform
maintain
$20 -> $19
2026-02-23
Reason
RBC Capital
Price Target
$20 -> $19
2026-02-23
maintain
Outperform
Reason
RBC Capital lowered the firm's price target on Select Medical to $19 from $20 and keeps an Outperform rating on the shares. The stock declined about 7% on Friday after the company reported a Q4 adjusted EBITDA miss and softer-than-expected 2026 guidance, though the firm is encouraged that management does not expect a material headwind related to the high-cost outlier threshold within its CIRH segment in 2026, the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for SEM
Unlock Now

People Also Watch